APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Embolotherapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Embolotherapy Industry Growth and Trends Forecast to 2032

Report ID 173894100122 December 2025111 pages

Choose your research edition.

Industry ResearchEmbolotherapy Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Embolotherapy Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Embolotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Embolotherapy Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Embolotherapy Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global Embolotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Embolotherapy market include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Embolotherapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Embolotherapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Embolotherapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Embolotherapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Embolotherapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Embolotherapy Market by Company

Medtronic

Boston Scientific

Terumo

Penumbra, Inc.

Johnson & Johnson

Sirtex

Merit Medical

Varian

Stryker

Jiangsu Hengrui Pharmaceuticals Co., Ltd

Cook Medical

Kaneka

Meril Life Sciences

Peijia Medical Limited

Wallaby Medical

MicroPort Scientific Corporation

Shandong Visee Medical Devices Co.,Ltd

Beijing Taijie Weiye Technology

Embolotherapy Segment by Type

Microspheres for Embolization

Embolism Particles

Embolic coils

Liquid Embolic Agent

Auxiliary Embolization Material

Others

Embolotherapy Segment by Application

Cancer

Peripheral Aascular Disease

Nerve System Disease

Others

Embolotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Embolotherapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Embolotherapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Embolotherapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Embolotherapy Market Share by Region (2021-2026) Table 4. Global Embolotherapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Embolotherapy Market Share by Region (2027-2032) Table 6. Global Embolotherapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Embolotherapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Embolotherapy Market Size Share by Type (2021-2026) Table 9. Global Embolotherapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Embolotherapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Embolotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Embolotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Embolotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Embolotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Embolotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Embolotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Embolotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Embolotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Embolotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Embolotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Embolotherapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Embolotherapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Embolotherapy Market Size Share by Application (2021-2026) Table 24. Global Embolotherapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Embolotherapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Embolotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Embolotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Embolotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Embolotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Embolotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Embolotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Embolotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Embolotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Embolotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Embolotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Embolotherapy Industry Trends Table 37. Embolotherapy Industry Drivers Table 38. Embolotherapy Industry Opportunities and Challenges Table 39. Embolotherapy Industry Restraints Table 40. Global Embolotherapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Embolotherapy Revenue Market Share by Company (2021-2026) Table 42. Global Embolotherapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Embolotherapy Key Company Headquarters & Area Served Table 44. Global Embolotherapy Company, Product Type & Application Table 45. Global Embolotherapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Embolotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Medtronic Company Information Table 49. Medtronic Business Overview Table 50. Medtronic Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Medtronic Embolotherapy Product Portfolio Table 52. Medtronic Recent Development Table 53. Boston Scientific Company Information Table 54. Boston Scientific Business Overview Table 55. Boston Scientific Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Boston Scientific Embolotherapy Product Portfolio Table 57. Boston Scientific Recent Development Table 58. Terumo Company Information Table 59. Terumo Business Overview Table 60. Terumo Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Terumo Embolotherapy Product Portfolio Table 62. Terumo Recent Development Table 63. Penumbra, Inc. Company Information Table 64. Penumbra, Inc. Business Overview Table 65. Penumbra, Inc. Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Penumbra, Inc. Embolotherapy Product Portfolio Table 67. Penumbra, Inc. Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Embolotherapy Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Sirtex Company Information Table 74. Sirtex Business Overview Table 75. Sirtex Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sirtex Embolotherapy Product Portfolio Table 77. Sirtex Recent Development Table 78. Merit Medical Company Information Table 79. Merit Medical Business Overview Table 80. Merit Medical Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merit Medical Embolotherapy Product Portfolio Table 82. Merit Medical Recent Development Table 83. Varian Company Information Table 84. Varian Business Overview Table 85. Varian Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Varian Embolotherapy Product Portfolio Table 87. Varian Recent Development Table 88. Stryker Company Information Table 89. Stryker Business Overview Table 90. Stryker Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Stryker Embolotherapy Product Portfolio Table 92. Stryker Recent Development Table 93. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information Table 94. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview Table 95. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio Table 97. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development Table 98. Cook Medical Company Information Table 99. Cook Medical Business Overview Table 100. Cook Medical Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cook Medical Embolotherapy Product Portfolio Table 102. Cook Medical Recent Development Table 103. Kaneka Company Information Table 104. Kaneka Business Overview Table 105. Kaneka Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Kaneka Embolotherapy Product Portfolio Table 107. Kaneka Recent Development Table 108. Meril Life Sciences Company Information Table 109. Meril Life Sciences Business Overview Table 110. Meril Life Sciences Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Meril Life Sciences Embolotherapy Product Portfolio Table 112. Meril Life Sciences Recent Development Table 113. Peijia Medical Limited Company Information Table 114. Peijia Medical Limited Business Overview Table 115. Peijia Medical Limited Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Peijia Medical Limited Embolotherapy Product Portfolio Table 117. Peijia Medical Limited Recent Development Table 118. Wallaby Medical Company Information Table 119. Wallaby Medical Business Overview Table 120. Wallaby Medical Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Wallaby Medical Embolotherapy Product Portfolio Table 122. Wallaby Medical Recent Development Table 123. MicroPort Scientific Corporation Company Information Table 124. MicroPort Scientific Corporation Business Overview Table 125. MicroPort Scientific Corporation Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. MicroPort Scientific Corporation Embolotherapy Product Portfolio Table 127. MicroPort Scientific Corporation Recent Development Table 128. Shandong Visee Medical Devices Co.,Ltd Company Information Table 129. Shandong Visee Medical Devices Co.,Ltd Business Overview Table 130. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio Table 132. Shandong Visee Medical Devices Co.,Ltd Recent Development Table 133. Beijing Taijie Weiye Technology Company Information Table 134. Beijing Taijie Weiye Technology Business Overview Table 135. Beijing Taijie Weiye Technology Embolotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Beijing Taijie Weiye Technology Embolotherapy Product Portfolio Table 137. Beijing Taijie Weiye Technology Recent Development Table 138. North America Embolotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Embolotherapy Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Embolotherapy Market Share by Country (2021-2026) Table 141. North America Embolotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Embolotherapy Market Share Forecast by Country (2027-2032) Table 143. Europe Embolotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Embolotherapy Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Embolotherapy Market Share by Country (2021-2026) Table 146. Europe Embolotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Embolotherapy Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Embolotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Embolotherapy Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Embolotherapy Market Share by Country (2021-2026) Table 151. Asia-Pacific Embolotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Embolotherapy Market Share Forecast by Country (2027-2032) Table 153. Latin America Embolotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Embolotherapy Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Embolotherapy Market Share by Country (2021-2026) Table 156. Latin America Embolotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Embolotherapy Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Embolotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Embolotherapy Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Embolotherapy Market Share by Country (2021-2026) Table 161. Middle East & Africa Embolotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Embolotherapy Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Embolotherapy Product Image Figure 3. Global Embolotherapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Embolotherapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Embolotherapy Market Share by Region: 2025 VS 2032 Figure 6. Global Embolotherapy Market Share by Region (2021-2032) Figure 7. North America Embolotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Embolotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Embolotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Embolotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Embolotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Microspheres for Embolization Image Figure 13. Global Microspheres for Embolization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Embolism Particles Image Figure 15. Global Embolism Particles Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Embolic coils Image Figure 17. Global Embolic coils Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Liquid Embolic Agent Image Figure 19. Global Liquid Embolic Agent Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Auxiliary Embolization Material Image Figure 21. Global Auxiliary Embolization Material Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Embolotherapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Embolotherapy Market Share by Type 2025 VS 2032 Figure 26. North America Embolotherapy Market Size Share by Type (2021-2032) Figure 27. Europe Embolotherapy Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Embolotherapy Market Size Share by Type (2021-2032) Figure 29. Latin America Embolotherapy Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Embolotherapy Market Size Share by Type (2021-2032) Figure 31. Cancer Image Figure 32. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Peripheral Aascular Disease Image Figure 34. Global Peripheral Aascular Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nerve System Disease Image Figure 36. Global Nerve System Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Embolotherapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Embolotherapy Market Share by Application 2025 VS 2032 Figure 41. North America Embolotherapy Market Size Share by Application (2021-2032) Figure 42. Europe Embolotherapy Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Embolotherapy Market Size Share by Application (2021-2032) Figure 44. Latin America Embolotherapy Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Embolotherapy Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Embolotherapy Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Embolotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Embolotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Embolotherapy Market Share by Country (2021-2032) Figure 51. Europe Embolotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Embolotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Embolotherapy Market Share by Country (2021-2032) Figure 54. Asia-Pacific Embolotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Embolotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Embolotherapy Market Share by Country (2021-2032) Figure 57. Latin America Embolotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Embolotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Embolotherapy Market Share by Country (2021-2032) Figure 60. Middle East & Africa Embolotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Embolotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Embolotherapy Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Microspheres for Embolization
  • Embolism Particles
  • Embolic coils
  • Liquid Embolic Agent
  • Auxiliary Embolization Material
  • Others
Applications
  • Cancer
  • Peripheral Aascular Disease
  • Nerve System Disease
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • Terumo
  • Penumbra, Inc.
  • Johnson & Johnson
  • Sirtex
  • Merit Medical
  • Varian
  • Stryker
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd
  • Cook Medical
  • Kaneka
  • Meril Life Sciences
  • Peijia Medical Limited
  • Wallaby Medical
  • MicroPort Scientific Corporation
  • Shandong Visee Medical Devices Co.,Ltd
  • Beijing Taijie Weiye Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Embolotherapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Embolotherapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Embolotherapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Embolotherapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Embolotherapy Market Size (2021-2032)
  8. 1.5.1 North America Embolotherapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Embolotherapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Embolotherapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Embolotherapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Embolotherapy Market Size Growth Rate (2021-2032)
2 Embolotherapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Microspheres for Embolization
  3. 2.1.2 Embolism Particles
  4. 2.1.3 Embolic coils
  5. 2.1.4 Liquid Embolic Agent
  6. 2.1.5 Auxiliary Embolization Material
  7. 2.1.6 Others
  8. 2.2 Global Embolotherapy Market Size by Type
  9. 2.2.1 Global Embolotherapy Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Embolotherapy Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Embolotherapy Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Embolotherapy Market Size by Regions
  13. 2.3.1 North America Embolotherapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Embolotherapy Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Embolotherapy Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Embolotherapy Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Embolotherapy Market Size Breakdown by Type (2021-2026)
3 Embolotherapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer
  3. 3.1.2 Peripheral Aascular Disease
  4. 3.1.3 Nerve System Disease
  5. 3.1.4 Others
  6. 3.2 Global Embolotherapy Market Size by Application
  7. 3.2.1 Global Embolotherapy Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Embolotherapy Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Embolotherapy Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Embolotherapy Market Size by Regions
  11. 3.3.1 North America Embolotherapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Embolotherapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Embolotherapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Embolotherapy Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Embolotherapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Embolotherapy Industry Trends
  2. 4.2 Embolotherapy Industry Drivers
  3. 4.3 Embolotherapy Industry Opportunities and Challenges
  4. 4.4 Embolotherapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Embolotherapy Revenue (2021-2026)
  2. 5.2 Global Embolotherapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Embolotherapy Key Company Headquarters & Area Served
  4. 5.4 Global Embolotherapy Company, Product Type & Application
  5. 5.5 Global Embolotherapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Embolotherapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Embolotherapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Embolotherapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Embolotherapy Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Boston Scientific
  8. 6.2.1 Boston Scientific Company Information
  9. 6.2.2 Boston Scientific Business Overview
  10. 6.2.3 Boston Scientific Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Boston Scientific Embolotherapy Product Portfolio
  12. 6.2.5 Boston Scientific Recent Developments
  13. 6.3 Terumo
  14. 6.3.1 Terumo Company Information
  15. 6.3.2 Terumo Business Overview
  16. 6.3.3 Terumo Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Terumo Embolotherapy Product Portfolio
  18. 6.3.5 Terumo Recent Developments
  19. 6.4 Penumbra, Inc.
  20. 6.4.1 Penumbra, Inc. Company Information
  21. 6.4.2 Penumbra, Inc. Business Overview
  22. 6.4.3 Penumbra, Inc. Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Penumbra, Inc. Embolotherapy Product Portfolio
  24. 6.4.5 Penumbra, Inc. Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Embolotherapy Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Sirtex
  32. 6.6.1 Sirtex Company Information
  33. 6.6.2 Sirtex Business Overview
  34. 6.6.3 Sirtex Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sirtex Embolotherapy Product Portfolio
  36. 6.6.5 Sirtex Recent Developments
  37. 6.7 Merit Medical
  38. 6.7.1 Merit Medical Company Information
  39. 6.7.2 Merit Medical Business Overview
  40. 6.7.3 Merit Medical Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merit Medical Embolotherapy Product Portfolio
  42. 6.7.5 Merit Medical Recent Developments
  43. 6.8 Varian
  44. 6.8.1 Varian Company Information
  45. 6.8.2 Varian Business Overview
  46. 6.8.3 Varian Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Varian Embolotherapy Product Portfolio
  48. 6.8.5 Varian Recent Developments
  49. 6.9 Stryker
  50. 6.9.1 Stryker Company Information
  51. 6.9.2 Stryker Business Overview
  52. 6.9.3 Stryker Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Stryker Embolotherapy Product Portfolio
  54. 6.9.5 Stryker Recent Developments
  55. 6.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
  56. 6.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
  57. 6.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
  58. 6.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
  60. 6.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
  61. 6.11 Cook Medical
  62. 6.11.1 Cook Medical Company Information
  63. 6.11.2 Cook Medical Business Overview
  64. 6.11.3 Cook Medical Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cook Medical Embolotherapy Product Portfolio
  66. 6.11.5 Cook Medical Recent Developments
  67. 6.12 Kaneka
  68. 6.12.1 Kaneka Company Information
  69. 6.12.2 Kaneka Business Overview
  70. 6.12.3 Kaneka Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Kaneka Embolotherapy Product Portfolio
  72. 6.12.5 Kaneka Recent Developments
  73. 6.13 Meril Life Sciences
  74. 6.13.1 Meril Life Sciences Company Information
  75. 6.13.2 Meril Life Sciences Business Overview
  76. 6.13.3 Meril Life Sciences Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Meril Life Sciences Embolotherapy Product Portfolio
  78. 6.13.5 Meril Life Sciences Recent Developments
  79. 6.14 Peijia Medical Limited
  80. 6.14.1 Peijia Medical Limited Company Information
  81. 6.14.2 Peijia Medical Limited Business Overview
  82. 6.14.3 Peijia Medical Limited Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Peijia Medical Limited Embolotherapy Product Portfolio
  84. 6.14.5 Peijia Medical Limited Recent Developments
  85. 6.15 Wallaby Medical
  86. 6.15.1 Wallaby Medical Company Information
  87. 6.15.2 Wallaby Medical Business Overview
  88. 6.15.3 Wallaby Medical Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Wallaby Medical Embolotherapy Product Portfolio
  90. 6.15.5 Wallaby Medical Recent Developments
  91. 6.16 MicroPort Scientific Corporation
  92. 6.16.1 MicroPort Scientific Corporation Company Information
  93. 6.16.2 MicroPort Scientific Corporation Business Overview
  94. 6.16.3 MicroPort Scientific Corporation Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 MicroPort Scientific Corporation Embolotherapy Product Portfolio
  96. 6.16.5 MicroPort Scientific Corporation Recent Developments
  97. 6.17 Shandong Visee Medical Devices Co.,Ltd
  98. 6.17.1 Shandong Visee Medical Devices Co.,Ltd Company Information
  99. 6.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
  100. 6.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
  102. 6.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments
  103. 6.18 Beijing Taijie Weiye Technology
  104. 6.18.1 Beijing Taijie Weiye Technology Company Information
  105. 6.18.2 Beijing Taijie Weiye Technology Business Overview
  106. 6.18.3 Beijing Taijie Weiye Technology Embolotherapy Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
  108. 6.18.5 Beijing Taijie Weiye Technology Recent Developments
7 North America
  1. 7.1 North America Embolotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Embolotherapy Market Size by Country (2021-2026)
  3. 7.3 North America Embolotherapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Embolotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Embolotherapy Market Size by Country (2021-2026)
  3. 8.3 Europe Embolotherapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Embolotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Embolotherapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Embolotherapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Embolotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Embolotherapy Market Size by Country (2021-2026)
  3. 10.3 South America Embolotherapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Embolotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Embolotherapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Embolotherapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst